Synthesis and RP HPLC studies of biologically active semicarbazides
665
ppm; 13C NMR (62.5 MHz, DMSO-d6): d = 14.49 (CH3),
31.23 (CH2), 63.36 (CH2), 114.86, 124.06, 124.96, 128.82,
144.42, 144.99, 149.22, 154.54 (12 9 Carom), 158.42
(C=O) ppm.
with dilute hydrochloric acid. The precipitate was filtered off
and then crystallized from ethanol.
2,4-Dihydro-5-[(1-methyl-1H-pyrrol-2-yl)methyl]-4-(2-
propenyl)-3H-1,2,4-triazol-3-one (5b, C11H14N4O)
Yield 1.65 g (76%); m.p.: 110–112 °C; IR (KBr):
2,4-Dihydro-5-(phenylmethyl)-4-(2-propenyl)-3H-1,2,4-
triazol-3-one (13b, C12H13N3O)
m = 3,283, 3,088, 3,015, 2,854, 1,697, 1,647, 1,461 cm-1
;
1H NMR (300 MHz, DMSO-d6): d = 3.49 (s, 3H), 3.83 (s,
2H), 4.12–4.14 (m, 2H), 4.92–5.13 (m, 2H), 5.66–5.83 (m,
1H), 5.88–6.66 (m, 3H, pyrrol-H), 11.52 (s, NH) ppm; 13C
NMR (62.5 MHz, DMSO-d6): d = 22.17 (CH2), 32.04
(CH3), 40.86 (CH2), 104.95 (CH), 106.51 (Carom), 115.14
(CH2), 121.14, 123.62, 131.36, 143.80 (5 9 Carom), 153.38
(C=O) ppm.
Yield 1.57 g (73%); m.p.: 105–108 °C; IR (KBr):
m = 3,143, 3,064, 2,780, 1,702, 1,641, 1,449 cm-1 1H
;
NMR (300 MHz, DMSO-d6): d = 3.30–3.45 (m, 2H), 4.10
(s, 2H), 4.66–5.05 (m, 2H), 5.40–5.70 (m, 1H), 6.93–7.32
(m, 5H, phenyl-H), 11.64 (s, NH) ppm; 13C NMR
(62.5 MHz, DMSO-d6): d = 31.44 (CH2), 40.05 (CH2),
116.55 (CH2), 126.85 (CH), 128.54, 128.64, 132.48,
135.19, 146.23 (7 9 Carom), 154.81 (C=O) ppm.
2,4-Dihydro-4-(2-propenyl)-5-(pyridin-2-yl)-3H-1,2,4-
triazol-3-one (9b, C10H10N4O)
4,40-(Methylenedi-4,1-phenylene)bis(5-ethyl-2,4-
dihydro-3H-1,2,4-triazol-3-one) (15b, C21H22N6O2)
Yield 2.61 g (68%); m.p.: 308–310 °C; IR (KBr):
Yield 1.37 g (68%); m.p.: 183–184 °C; IR (KBr):
m = 3,180, 3,014, 2,953, 2,814, 1,964, 1,640, 1,454 cm-1
;
m = 3,176, 3,066, 2,955, 1,698, 1,580, 1,417 cm-1 1H
;
1H NMR (300 MHz, DMSO-d6): d = 3.50–3.59 (m, 2H),
4.11–4.77 (m, 2H), 5.11–5.16 (m, 1H), 7.02–7.30 (m, 4H,
pyridine-H), 11.05 (s, NH) ppm; 13C NMR (62.5 MHz,
DMSO-d6): d = 39.00 (CH2), 42.29 (CH2), 114.71 (CH),
132.20, 136.00, 142.62, 145.61, 147.47 (6 9 Carom), 153.75
(C=O) ppm.
NMR (300 MHz, DMSO-d6): d = 1.00 (t, J = 4.6 Hz,
6H), 2.36 (q, J = 7.4 Hz, 4H), 3.32 (s, 2H), 7.05–7.94 (m,
8H, phenyl-H), 11.59 (s, 2NH) ppm; 13C NMR (62.5 MHz,
DMSO-d6): d = 8.30 (2 9 CH3), 17.92 (2 9 CH2), 39.05
(CH2), 126.05, 128.32, 139.98 (14 9 Carom), 146.54
(2 9 C=O) ppm.
2,4-Dihydro-4-(2-propenyl)-5-[(pyridin-4-yl)methyl]-3H-
1,2,4-triazol-3-one (10b, C11H12N4O)
UV-Vis spectroscopy
Yield 1.60 g (74%); m.p.: 255–257 °C; IR (KBr):
m = 3,180, 3,065, 2,790, 2,654, 1,703, 1,639, 1,457 cm-1
;
1H NMR (300 MHz, DMSO-d6): d = 4.25 (s, 2H),
4.21–4.27 (m, 2H), 4.93–5.09 (m, 2H), 5.71–5.84 (m, 1H),
7.95–8.88 (m, 4H, pyridine-H), 11.79 (s, NH) ppm; 13C
NMR (62.5 MHz, DMSO-d6): d = 29.80 (CH2), 39.05
(CH2), 40.81 (CH2), 115.45 (CH), 126.38, 131.16, 139.92,
142.93 (6 9 Carom), 154.29 (C=O) ppm.
UV-Vis spectra were recorded in water (buffer)-methanol
(1:1) solution on a UV-160A Shimadzu Spectrophotome-
ter. Quartz cuvettes (1 cm) were used for measurements.
Liquid chromatography
HPLC was carried out using a liquid chromatograph
(Knauer, Berlin, Germany) with a dual pump, a 20-mm3
simple injection valve and a UV–visible detector at
254 nm. The samples were prepared as solutions in
methanol.
4-Cyclohexyl-2,4-dihydro-5-[(pyridin-4-yl)methyl]-3H-
1,2,4-triazol-3-one (11b, C14H18N4O)
Yield 2.06 g (80%) m.p.: 237–238 °C; IR (KBr):
m = 3,231, 3,075, 2,916, 1,687, 1,564 cm-1 1H NMR
;
(300 MHz, DMSO-d6): d = 0.96–2.06 (m, 10H), 3.48–3.61
(m, 1H), 4.00 (s, 2H), 7.27–8.53 (m, 4H, pyridine-H), 11.48
(s, NH) ppm; 13C NMR (62.5 MHz, DMSO-d6): d = 24.53
(CH2), 25.14 (2 9 CH2), 28.97 (2 9 CH2), 30.94 (CH2),
53.97 (CH), 123.92, 144.96, 145.06, 149.74 (6 9 Carom),
154.69 (C=O) ppm.
RP-8 chromatography
A Hypersil MOS2 C8 (5 lm, 150 9 4.6 mm) column was
used as the stationary phase. The mobile phase consisted of
different volume mixtures of methanol and 20 mM acetate
buffer (KCl) as the aqueous phase to give pH 7.4. The
methanol concentration ranged from 0.10 to 0.70 at 0.1
(0.05) intervals. The flow rate was 1 cm3 min-1 at room
temperature. The retention time of an unretained solute (t0)
was determined by the injection of a small amount of
acetone dissolved in water.
4-(4-Ethoxyphenyl)-2,4-dihydro-5-[(pyridin-4-yl)methyl]-
3H-1,2,4-triazol-3-one (12b, C16H16N4O2)
Yield 2.10 g (71%); m.p.: 180–181 °C; IR (KBr):
m = 3,231, 3,074, 2,917, 1,678, 1,475 cm-1 1H NMR
;
(300 MHz, DMSO-d6): d = 1.32 (t, J = 6.9 Hz, 3H), 3.82
(s, 2H), 4.05 (q, J = 6.9 Hz, 2H), 6.94–7.07 (m, 4H,
phenyl-H), 7.14–8.41 (m, 4H, pyridine-H), 11.76 (s, NH)
123